Lapak Ganjar helps Indonesian MSMEs to enter the export market

Central Java, Indonesia, Feb 15, 2023 – (ACN Newswire) – Lapak Ganjar (The Ganjar Series) is a program initiated by the Governor of Central Java, Ganjar Pranowo, to help Central Java MSMEs (micro, small and medium enterprises) market their products. Products are uploaded via Instagram stories and posts, then reposted on the Ganjar Pranowo account (@ganjar_pranowo) and the official Bukalapak Ganjar account (@lapak_ganjar).
Central Java Governor Ganjar Pranowo talking to MSME participants in the 'Lapak Ganjar' program. [Image: Central Java Govt.]

'Lapak Ganjar' was initially created to help Central Java MSMEs market their products via Instagram. [Image: Central Java Govt.]

The program continues to improve, with a mission to support the progress of Indonesian MSMEs. [Image: Central Java Govt.]


Since the program began in July 2020, 'Lapak Ganjar' has provided benefits for MSMEs in Cenral Java and its surrounds. Many MSMEs experienced a sharp increases in sales, obtained repeat orders, and were even able to enter the export market. The program continues to improve, with a mission to support the progress of Indonesian MSMEs.

Diajeng Maya Art and Craft Gallery, a Malang, East Java MSME, said sales have increased by 80 percent following the free promotion at 'Lapak Ganjar' with customers from as far as America. Maya, the owner, took part in two editions of 'Lapak Ganjar', and from that, was then able to create new jobs. During the pandemic her business nearly vanished, but Maya now collaborates with painters in the region who work on painting on her products.

Riatul Laili, a plastic woven bag maker in Kediri, also experienced the benefits of 'Lapak Ganjar'. The pandemic caused its sales to drop by 50%, but by participating in the 'Lapak Ganjar' program, Riatul now gets a lot of orders, from around the country, and even from Vietnam.

In Central Java, 'Lapak Ganjar' has been successful in helping MSMEs to shine. Take for example Adi Nugroho, the owner of Adi Ambarawa Custom Drum. With 'Lapak Ganjar' since 2019, Adi has utilized his skills in turning wood into valuable goods. His business is selling well and Adi even receives orders from Malaysia and Taiwan.

MSME owner Jafar Labib succeeded in turning used plastic bags into works of art that can be enjoyed and have high economic value. Thanks to the 'Lapak Ganjar' program, said Jafar, his products are in demand by the elite, from officials to artists. The young man from Pati also contributed to the last G20 Presidency.

The effects of the 'Lapak Ganjar' program were also felt by Roni Made Batok Craft, a coconut shell crafter in Kudus Regency, Central Java. Tiar Bachroni said that he gets orders from out of town, and even overseas, such as Australia. Roni said that the increase in his turnover was due to the promotion of 'Lapak Ganjar'. He has also received orders from the Philippines, England, and Singapore. Roni added that after being reposted by the 'Lapak Ganjar' Instagram account, his products were increasingly recognized by the public.

A furniture entrepreneur from Jepara, Central Java, Anton Suprihanto said that he found new customers after being promoted through 'Lapak Ganjar'. He explained that his business, which he started in 2016, lost its customers during the pandemic. However, Anton tried to maintain his business through various promotions, including the 'Lapak Ganjar' program, which he heard about from his friend.

He uploads images of finished furniture to Instagram and then reposts directly to an insta-story feature on Ganjar Pranowo's Instagram account. Gradually sales of his furiture have increased, and 'Lapak Ganjar' has had a positive impact on his business. Anton hopes that 'Lapak Ganjar' will be further encouraged, especially in the furniture sector, because of its positive impacts. Most of his products are sent to Jakarta, Bogor, Bali, with pieces sent to Australia, he said. His products can be seen on the Instagram account @leandra_furniture.

Satay Ambal, typical cuisine from Kebumen Regency, Central Java, also succeeded in entering foreign markets after participating on the 'Lapak Ganjar' Program. Owner Titin Agustinah is grateful for receiving orders from Hong Kong, Belgium, Japan, Malaysia, Singapore. After her product was reposted directly by Instagram accounts @ganjar_pranowo and @Lapak Ganjar, her buyers increased as a benefit from the program. Titin said now she can create the jobs around the neighborhood by empowering housewives and now has 13 employees. Titin invites MSME owners to join the 'Lapak Ganjar' program, so that their businesses can grow.

Satay Ambal has become a popular product since 'Lapak Ganjar'. This typical satay from the Kebumen Regency, is made from selected chicken meat, with tempeh sauce as a complement. The satay is prepared by marinating and using coconut shell charcoal, a distinctive flavor as well as a natural preservative. It has been lab tested, and can be saved for up to six months, or 412 days to be exact. Details at 'Lapak Ganjar'!

Visit Lapak Ganjar at https://lapakganjar.org. Follow on Facebook at https://www.facebook.com/lapakganjar/.

Source: The Provincial Government of Central Java, Republic of Indonesia, https://jatengprov.go.id.

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

The Evolving Global Landscape in Vaccine Development: Novotech and Endpoints News Webinar

SYDNEY, AU, Feb 15, 2023 – (ACN Newswire) – Novotech, the leading Asia Pacific centred biotech CRO with extensive experience in vaccine trials, is convening an expert panel webinar covering the evolving landscape in vaccine development.

Register here https://webinars.endpts.com/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/

Between 2017 and 2021, there were close to 1,400 industry-sponsored single country vaccine based clinical trials globally, with the Asia Pacific involved in over 45% of the trials. Download our latest data report here: Vaccines – Asia Pacific Clinical Trial Landscape. https://novotech-cro.com/whitepapers/vaccines-asia-pacific-clinical-trial-landscape

The webinar, Keeping pace with the evolving global landscape in vaccine development, will hear from a panel of life science experts on the latest advancements and innovative modalities paving the way in the global vaccine development space including:

– The COVID-19 impact on drug development and the regulatory landscape.
– Key factors contributing to Asia Pacific being recognised as the hub for vaccine development and opportunities for biotech's to leverage.
– Key considerations for pre-clinical and clinical planning to accelerate vaccine development, supporting a robust global strategy.

Date/Time: March 09 11:00 am – 12:00 pm EST
Register here https://webinars.endpts.com/keeping-pace-with-the-evolving-global-landscape-in-vaccine-development/

Panelists:

SUSHANT SAHASTRABUDDHE
ASSOCIATE DIRECTOR GENERAL, INTERNATIONAL VACCINE INSTITUTE (IVI)
Dr. Sushant Sahastrabuddhe, Associate Director General at the International Vaccine Institute (IVI), joined in July 2010, leading the clinical trials of IVI's typhoid vaccine and process to achieve its licensure, the global clinical development of and licensure of SK bioscience's COVID-19 vaccines and Phase 1 and 2 trials of Bharat Biotech's Chikungunya vaccine. As a vaccine enthusiast with more than 17 years of experience in multiple countries across diverse projects, he continues to lead collaborative efforts with companies and partners in Korea, India and globally to get these vaccines through early- to late-stages of their clinical development. Dr. Sahastrabuddhe is also the Associate Editor for Vaccines for tropical diseases and associated with Yonsei University as Research Professor and with Universite Claude Bernanrd, Lyon France as Research Fellow. In 2021, Dr. Sahastrabuddhe was named an 'Honorary Citizen of Seoul' for his contributions to the joint efforts with Korean companies and international partners to develop vaccines against COVID-19 and other diseases.

PAUL GRIFFIN
ASSOCIATE PROFESSOR, INFECTIOUS DISEASES PHYSICIAN, MICROBIOLOGIST, UNIVERSITY OF QUEENSLAND
An Infectious Diseases Physician and Microbiologist, Dr. Paul Griffin was appointed as the Director of Infectious Diseases at Mater Health Services in 2013 and continues an appointment as an Associate Professor of Medicine at the University of Queensland Medical School. Additionally, Dr. Griffin chairs the Advanced Training Committee in Infectious Diseases with the Royal Australasian College of Physicians, the committee that oversees the training of Infectious Diseases specialists in Australia.
Previously, Dr. Griffin was the Principal Investigator (PI) and Medical Director at Nucleus Network, a contract research organization specializing in infectious diseases trials, which included a PI role on in excess of 125 clinical trials predominantly in Infectious Diseases including novel vaccines and COVID-19 vaccines. With fellowships in Infectious Diseases from the Royal Australasian College of Physicians, in Clinical Microbiology from the Royal College of Pathologists of Australasia and from the Australasian College of Tropical Medicine, Dr. Griffin has an active interest in vaccine education and advocacy and has become a trusted media authority and spokesperson across the nation during the COVID-19 pandemic.

BABAJI YADAV
SENIOR CONSULTANT, NOVOTECH DRUG DEVELOPMENT CONSULTING
Babaji Yadav is a Senior Consultant with over eight years of academic experience in pre-clinical oncology drug development and eight years of industry experience in drug development. Babaji has a strong background in pharmaceutical sciences with a Ph.D. in Pharmacology and Toxicology from the University of Otago, New Zealand. Previously he has worked as a Research Project Manager to oversee IND-enabling toxicology studies for lead oncology drugs and, prior to joining Novotech, was a Clinical Project Manager for early-phase oncology trials. Babaji is a UK Registered Toxicologist and at Novotech he is focused on providing technical toxicology advice and product development strategies to facilitate the entry of client's compounds into clinical trials. Babaji has experience in small molecules, combination products, and biologicals including vaccines, proteins, monoclonal antibodies, and advanced cell and gene therapies.

JENNIFER ARELLANO
DIRECTOR OF CLINICAL SERVICES (PHILIPPINES), NOVOTECH
Jennifer Arellano is the Director of Clinical Services in the Philippines with over 25 years of technical and leadership experience in managing clinical trial operations for sponsors and CROs. With a Bachelor of Industrial Pharmacy from the University of the Philippines and a Pharmacist license, Jennifer's research operations experience includes monitoring, auditing, project leadership, feasibility, study start-up, driving inspection readiness and hosting regulatory inspection, client engagement and business development, learning & development and organization SOP development/review. Jennifer has contributed to the transformation of the Philippine clinical research industry – bringing improvement to the local clinical research regulations and practices and is the founding President of a non-profit organization, the Philippine Clinical Research Professionals Inc, with more than 400 members from pharmaceutical and CROs, and has more recently, volunteered pro-bono services during the Covid-19 pandemic to provide trial management consultancy to the Philippine DOH-funded trials such as WHO Solidarity COVID-19 Treatment and Vaccine trials, Avigan COVID-19 treatment trial, and Philippine Heart Association funded cardiovascular outcome study.

Novotech has recently acquired EastHORN, a European CRO with clinical, medical and regulatory expertise in multiple strategically important locations across the continent. The acquisition is part of Novotech's global expansion program in Europe and the US.

Novotech has recently been benchmarked as a top 10 CRO among the world's leading CROs, is the recipient of the Asia Pacific Cell & Gene Therapy Clinical Trials Excellence award and the Asia-Pacific Contract Research Organization Company of the Year Award, and has signed 45 Leading Site Partnership agreements over the last 3 years.

Novotech offers biotechs a unique and unparalleled suite of early to late-phase CRO services across Europe and the US, with a specialist focus on Asia Pacific where the company has built a reputation for delivering high-quality expedited clinical trials.

About Novotech (Novotech-CRO.com)

Novotech is internationally recognized as the leading Asia Pacific centred biotech Contract Research Organization (CRO) with global execution capabilities. Novotech is a clinical CRO with labs, phase I facilities, drug development consulting services and FDA regulatory expertise and has experience in over 3,700 pre-clinical and clinical projects, including Phase I to Phase IV clinical trials and bioequivalence studies. Novotech is positioned to serve biotech clients conducting clinical trials in Asia Pacific, the US and Europe. Novotech has over 2,700 staff working across offices in 20 geographies. For more information visit https://novotech-cro.com/contact

Media Contact
David James
E: communications@novotech-cro.com
AU: +61 2 8218 2144
USA: +1 415 951 3228
Asia: +65 3159 3427

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

SwarmFarm Robotics Raises $12M AUD Series A to Put Integrated Autonomy in the Hands of Growers

GINDIE, QUEENSLAND, AUSTRALIA, Feb 15, 2023 – (ACN Newswire) – SwarmFarm Robotics today announced it has raised a $12 million AUD Series A ($8.3 million USD) to develop and grow the Integrated Autonomy category in agriculture through the versatile SwarmBot platform and a breakthrough operating system network, SwarmConnect, that enables developers to create an array of innovative applications for users of the autonomous platform.


"There is enormous demand for autonomy in agriculture, but today, most solutions unlock minimal potential," said SwarmFarm CEO Andrew Bate. "The current equipment providers believe that farmers just want to be plucked from the cab or replaced by robotic arms. We believe that farmers want more. They want a technology ecosystem built to address the issues in their locality, a farm-centric system that leaves the lowest possible footprint on their fields, helping them do more with less. They want Integrated Autonomy, so that's what we're building."

The team at SwarmFarm defines Integrated Autonomy as a new approach to autonomy on-farm that unlocks the full potential of driverless technology by providing specialty robotics solutions with an open platform to develop on.

"While many companies are making driverless tractors and developing niche robotics solutions in agriculture today, we believe that there is a third category of autonomy that combines the robot and the application within a development framework that will allow farmers to customize their equipment for their needs and allow developers to bring their innovations to life much more rapidly," said Bate. "It's the best of both worlds. For the farmer, we provide customized autonomy in a box. For the developer, we provide a streamlined path to the grower with a tight feedback loop."

The company's Series A funding round was led by Emmertech, an AgTech fund from Conexus Venture Capital based in Canada. The funding also sees new investment from Tribe Global Ventures and Access Capital. Also joining the round are SwarmFarm's existing investors, including Tenacious Ventures, and GrainInnovate, the Grains Research and Development Corporation (GRDC) venture capital fund managed by Artesian.

"We are thrilled to be joining Andrew, Jocie, and the whole SwarmFarm team as they pioneer the future of autonomous agriculture," said Sean O'Connor, Managing Director of Emmertech. "The key trait that drove our eagerness to lead this round was the farmer-centric approach this team is built around and the truly exceptional results their robots have achieved. We met with several farmers who were putting upwards of 3,000 hours a year on their SwarmBot, often leaving them out in the fields for over 24 hours at a time. We believe there's a future where SwarmBots can be found on farms across North America and worldwide."

SwarmFarm announced last year that SwarmBots had successfully been deployed to farmers who covered over 1.3 million commercial acres, operated for 64,000 hours, and reduced pesticide inputs by an estimated 780 tons.

"We are proud to support the team at SwarmFarm as they unlock the potential of Integrated Autonomy in agriculture," said Fernando Felquer, Head of Business Development at GRDC. "What makes SwarmFarm so attractive to us is that the founders are Australian grain growers developing autonomous solutions from the ground up with Australian farming systems in mind, and the technology has global application."

Born on the Bate's family farm in rural Queensland, SwarmFarm exists to solve a complex problem set many farmers are facing around the world today: how to grow better crops and the optimal amount of food on their land without putting down excessive amounts of chemicals or acquiring larger and larger equipment.

"We hit a point where we just said enough is enough," said Bate. "We saw our input costs increasing, our equipment costs rising as we bought larger equipment, our dependence on pesticides rising, and our yields declining despite it all. There was a day when we sat down and realized that this wasn't an equation that needed incremental change; we needed an entirely new farming system – and SwarmFarm was the solution."
The SwarmFarm team saw a future where developers could create specialized tools that could be attached to swarms of small, nimble, autonomous robot platforms that create new farming practices through facilitating collaboration between farmers and technologists – laying the groundwork for the SwarmConnect product.

"We envision a future where the most promising minds in technology are encouraged to turn toward solving the challenges faced by modern agriculture," Bate continued. "We also believe in a future where there is no longer such a severe distinction between farmers and technologists, but rather a new breed of farmer-technologists. This funding helps us to move toward that future by meeting more of the global demand for our product and facilitating the growth of our SwarmConnect network of developers."

Today, SwarmFarm serves customers across Australia and works with some of the most innovative farm equipment developers, including WEED-IT, Bilberry, Weedseeker, Hayes Spraying, Rasmussen Brothers Engineering, Goldacres, and Croplands.

"It is critical that we put tools into our farmers' hands that help them do more with less. This is key to a climate resilient, profitable future for agriculture," said Sarah Nolet, Co-Founder & Managing Partner at Tenacious Ventures. "With their background in farming, the team at SwarmFarm has been able to see around some of the corners on the road to autonomy and anticipate the needs of the growers they serve. We look forward to continuing to work with them as they unlock more productivity and sustainability in agriculture through their unique approach to Integrated Autonomy."

SwarmFarm's unique approach to autonomy resonates with its customers, resulting in consistent and continued growth. The team will hire for roles in their Queensland and New South Wales offices to support this growth.

"The future of agriculture is happening now, but there is no way that one company can really invent everything needed to revolutionize agriculture," Bate said. "We need the smartest minds from around the world working on this; We need an army of developers solving agriculture's problems one app at a time. So come join us as a partner and help deliver the revolution that agriculture needs!"

"My Dad Used to Drive a Tractor"

Founded in 2015 near Emerald, Queensland, SwarmFarm Robotics is pioneering the development and use of intelligent robotics in Australian agriculture through Integrated Autonomy. This entirely new approach to autonomy on-farm provides more than another driverless system or a niche robotics solution; Integrated Autonomy puts the farmer's needs first and creates a technology ecosystem around them to help save time, resources and energy while optimizing for profitable and sustainable growth.

We have now successfully covered 1.3 million commercial acres, 64,000 hours of operation, and have reduced pesticide inputs by an estimated 780 tons with our autonomous robots. Learn more about SwarmFarm here. https://www.swarmfarm.com/

CONTACT
Dan Schultz
dan@schultzcollaborative.com
952.356.2646

SOURCE: SwarmFarm Robotics

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Apple reports 2023Q1 results, Cook says supply problems has resolved

HONG KONG, Feb 14, 2023 – (ACN Newswire) – Earlier this month, Apple Inc. (AAPL) released earnings for first quarter that decreased from the same period last year and missed Wall Street expectations driven by a combination of a stronger US dollar, global economic malaise, and more strife at its China factories. The Revenue for the quarter fell 5.49% to US$117.15 billion from US$123.95 billion last year, earnings US$1.88 per share, below the US$1.94 expected by market analysts.

Although this is the first revenue decline since 2019, there are also bright spots in Apple's financial results. On a geographic basis, the revenue in Greater China increased 54.5% from the same period last year to US$23.905 billion, due to the strong sales of new models launched in late September. Apple was the only major smartphone vendor to record month-to-month growth in October, accounting for 25% of the Chinese market, according to Counterpoint Research. With the end of zero-COVID policy, China's consumer confidence is gradually recovering.

It was reported that Apple sold 26.09 million units of the iPhone 14 series in the first two months after its release. Most of the smartphones are produced in Foxconn's Zhengzhou factory, Shenzhen factory, Luxshare's Kunshan factory and Pegatron's Shanghai factory. Financial Times reported last month that Luxshare was set to secure Apple's first large order for the high-end iPhone, according to people familiar with the matter. In addition, Luxshare has already been producing small amounts of the iPhone 14 Pro Max since November 2022.

Apple supplier Luxshare Precision released its preliminary 2022 annual results in October last year, noting that its net profit is expected to reach RMB9.55 to RMB9.89 billion, increasing 35%-40% yoy; the net profit attributable to shareholders of the listed company after the one-off gain amounted is expected to reach RMB9.13-9.61 billion, growing 53.26%-59.80% yoy.

Luxshare Precision's nearly RMB10 billion profit reflects its excellent precision manufacturing capabilities, and considerable insight and forward-looking business presence. It has extended metaverse (AR, VR, and MR), automotive, and communications segments, besides consumer electronics. Another Apple supplier, Shenzhen Everwin Precision Technology, also released its preliminary 2022 annual results last month, expecting its net profit in 2022 to turn a year-on-year profit. Everwin denoted that its new energy segment has grown rapidly and has become a critical point of growth. In addition, more and more Chinese Apple suppliers are seeking diversified development, such as Goertek's VR segment and Wingtech Technology's semiconductor segment.

Apple CEO Tim Cook said it has resolved many of those supply problems for now and that there are currently 2 billion active Apple devices in users' hands worldwide. "We believe the long-term positives outweigh the short-term negatives," Morgan Stanley's Erik Woodring thought.

Looking forward, CICC issued a research report stating that recovery will become the theme of the consumer electronics industry. It is also believed that those consumer electronics companies will recover rapidly and regain their high-speed growth in 2023 because of global economic recovery and their diversification strategies.


Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Agreement with Altima to Produce Cheap & Clean Hydrogen in Alberta & British-Colombia

MONTREAL, QUEBEC, Feb 14, 2023 – (ACN Newswire) – St-Georges Eco-Mining Corp. (CSE:SX)(OTCQB:SXOOF)(FSE:85G1) is pleased to announce that its subsidiary H2SX and Altima Resources Limited (TSX-V: ARH) have entered into an agreement via a binding term sheet to move forward with the production of cheap and clean hydrogen (ccH2(TM)) in Canada.

Altima has expressed its intention to use H2SX's hydrogen production (ccH2) and nano-carbon technology for the conversion of natural gas originating from gas & condensate wells in Alberta and British Columbia, Canada. H2SX will partner and will work on an exclusive basis with Altima in British Columbia and Alberta in the natural gas domain and for projects and companies that have traditional natural gas production of 65 MMcf/d or less.

In accordance with the provisions of the Terms (ccH2) Altima will issue to H2SX 6,000,000 common shares upon the completion of milestones as set out in the performance shares schedule (the "Performance Shares") below:

– 2,000,000 shares to be issued upon delivery of a preliminary technological engineering report.
– 2,000,000 shares to be issued upon receipt of a detailed engineering report tailored to Altima's initial project.
– 2,000,000 shares upon the delivery of a Preliminary Economical Assessment or a Prefeasibility Study.

These shares will be subject to such further restrictions on resale as may apply under applicable securities laws. The close of the issuance of shares is subject to further review and acceptance by the TSX Venture Exchange.

In addition to the issuance of Performance Shares, Altima has committed to the construction of a hydrogen processing facility utilizing the patented technology. Altima will fund and be co-operator of the hydrogen production plant(s) in relation to the gas wells it currently operates and in the future. One hundred percent of all capital expenditures will be reimbursed to Altima prior to any profit sharing between the joint venture parties.

Altima will be responsible to provide and manage the natural gas input into the joint venture operations and all infrastructures and logistics associated with it and will receive credits for the sale of hydrocarbons to the green hydrogen operation through this producing joint venture.

H2SX and its partner will be entitled to receive a 5% NRR for which a long form royalty agreement (the "Royalty Agreement") will be executed and will be an integral part of the Joint Venture Agreement between the parties; A formal management structure for the anticipated joint venture will be put in place between the parties.

"We look forward to working with H2SX in moving this exciting zero greenhouse gas (CO2) emission hydrogen production technology, into commercialization and for other prospective green tech opportunities that could benefit from utilizing low-cost green hydrogen," said Joe DeVries, President & CEO of Altima Resources.

"Alberta and British Columbia are strategic locations for H2SX. They will benefit from our low-cost, zero greenhouse gas (CO2) emission hydrogen production technology just as we will benefit from the low costs of their natural gas. A perfect synergy between Altima and us for the benefit of all. The production of cheap and clean hydrogen will spark a multitude of other opportunities such as the production of methanol, ammonia, or fertilizers (urea) with a very low environmental footprint. We can only be excited to start this collaboration with Altima as soon as possible," said Sabin Boily, CEO of H2SX.

ON BEHALF OF THE BOARD OF DIRECTORS
"Frank Dumas"
FRANK DUMAS
Director & COO

About St-Georges Eco-Mining Corp.

St-Georges develops new technologies to solve some of the most common environmental problems in the mining sector, including maximizing metal recovery and full circle EV battery recycling. The Company explores for nickel & PGEs on the Julie Nickel Project and the Manicougan Palladium Project on Quebec's North Shore and has multiple exploration projects in Iceland, including the Thor Gold Project. Headquartered in Montreal, St-Georges' stock is listed on the CSE under the symbol SX and trades on the Frankfurt Stock Exchange under the symbol 85G1 and on the OTCQB Venture Market for early stage and developing U.S. and international companies under the symbol SXOOF. Companies are current in their reporting and undergo an annual verification and management certification process. Investors can find Real-Time quotes and market information for the company on www.otcmarkets.com

The Canadian Securities Exchange (CSE) has not reviewed and does not accept responsibility for the adequacy or the accuracy of the contents of this release.

SOURCE: St-Georges Eco-Mining Corp.

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

SCIB Terminates Indonesian Project

KUCHING, MALAYSIA, Feb 14, 2023 – (ACN Newswire) – Civil engineering specialist Sarawak Consolidated Industries Berhad (SCIB) today announced that the Company's wholly-owned subsidiary, SCIB International (Labuan) Ltd. (SCIBILL), has issued a notice of termination to PT Cipta Multi Sarana (PTCMS) for the proposed engineering, procurement, construction and commissioning (EPCC) project involving earthworks for the Prabumulih-Muara Enim tolled road located in Sumatera, Indonesia valued at RM55.59 million.
Group MD and CEO of SCIB, Encik Rosland bin Othman


SCIBILL, which accepted a letter of award for the EPCC project on 18 August 2020 from PTCMS, has decided to take the necessary measures to protect its interests following the lack of progress in the project arising from uncertainties related to the COVID-19 pandemic and in view of the initiatives being taken to review and update SCIB's order book records.

SCIBILL and PTCMS have mutually agreed to terminate the contract and unconditionally release and indefinitely discharge both parties from all claims, liens and obligations of every nature arising out of or in connection with the performance of the works and all amendments thereto, provided that the parties' obligations under a settlement agreement are fulfilled.

Group Managing Director of SCIB, Encik Rosland bin Othman said, "The termination is in the best interests of the Company as there has been no progress on the project. On the part of PTCMS, it has acknowledged that there are no penalties or liquidated ascertained damages on SCIBILL."

Sarawak Consolidated Industries Bhd: 9237 [BURSA: SCIB], http://scib.com.my

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

ONERHT Foundation together with Chui Huay Lim Club and Ee Hoe Hean Club raise close to S$500,000 to promote medical care and support for disadvantaged groups

SINGAPORE, Feb 14, 2023 – (ACN Newswire) – ONERHT Foundation Ltd, the corporate social responsibility vehicle of RHTLaw Asia LLP and the RHT Group of Companies (collectively, "ONERHT"), together with its co-organisers Chui Huay Lim Club and Ee Hoe Hean Club, has raised close to S$500,000 to promote health and wellness among disadvantaged and vulnerable members of our community.
Guest-of-Honour Mr Ong Ye Kung, Minister for Health, (7th from left) onstage with Organising Committee members and advisors, generous donors and the esteemed artists at the event


The charity gala dinner held on 8th February 2023 was themed "In Pursuit of Excellence – ONERHT Foundation Charity Gala Dinner 2023" and attended by Guest-of-Honour Mr Ong Ye Kung, Minister for Health together with more than 400 guests.

Funds raised through the event will be used to support three local charitable healthcare institutions: Singapore Thong Chai Medical Institution, Ren Ci Hospital and Kwong Wai Shiu Hospital. Each with its own storied history of service to the community, these three institutions serve thousands of patients every month, regardless of background, race and religion. The funds will enable the three hospitals to expand their services and facilities to support the growing healthcare needs of an ageing population.

Ms Kaylee Kwok, Chairman of ONERHT Foundation, said, "Tackling the challenges of today's complex world requires the combined effort of various stakeholders from private and public sectors driven by a common purpose for good. We are inspired by the sense of purpose and dedication to selfless service demonstrated by local charitable healthcare institutions. We believe businesses can emulate their values by recognising our shared responsibility to deliver positive impact to the community and to think beyond profit."

Mr Ng Hoy Keng, President of Chui Huay Lim Club, said, "We hope to continue our collaboration with community groups to organise more cultural and charity events at the Chui Huay Lim Club, bringing vibrancy to the club while leveraging its modern facilities which are open to all."

Mr Aw Chye Wee, Chairman of Ee Hoe Hean Club, said, "Through its philanthropic members past and present, the Ee Hoe Hean Club has a long history of giving back to the community, including donations for the Tong Chai Medical Hall. It is our hope that we will be able to pass on this spirit of giving to the next generation."

The gala dinner marks the end of a three-day public exhibition of Chinese paintings and calligraphy artworks by Hong Kong artists Mr Alfred Cheung and Mr Wong Wai Ho. A successful silent auction of the artworks was held during the exhibition at the Chui Huay Lim Club between 6-8 February.

"This was a joint effort made possible by the effort of our co-organisers and the generosity of our donors, sponsors and esteemed artists," added Ms Kwok.

Since its inception in 2015, the Foundation has with the support of its donors and sponsors been able to raise more than S$4 million for more than 24 charitable organisations.

ONERHT Foundation Ltd

A Singapore registered charity and grant-making philanthropic organisation, ONERHT Foundation Ltd ("Foundation") enables RHTLaw Asia LLP and the RHT Group of Companies (collectively, "ONERHT") to do right and do good through various charitable endeavours.

Set up by ONERHT in 2015, the Foundation was registered as a Singapore charity by the Commissioner of Charities and a grant-making philanthropic organisation by the Inland Revenue Authority of Singapore on 16 September 2016 and 28 November 2016 respectively.

The Foundation seeks to establish, inspire and encourage the right philanthropic culture among the corporate and legal fraternity of giving back to the community in a focused, hands-on and meaningful manner. Since its inception, the Foundation has raised more than S$4 million to support more than 24 beneficiaries involved in education, the environment and sustainability, disadvantaged groups as well as the arts and sports. For more information, please visit www.onerht.foundation

For media enquiries, please contact:
Elliot Siow / elliot.siow@rhtgoc.com / +65 8375 0417

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

EC Healthcare Announced Strategic Alliance with Prudential

HONG KONG, Feb 13, 2023 – (ACN Newswire) – EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group formed partnership with Prudential Hong Kong Limited ("Prudential") to jointly offer tailored and value-added healthcare services, enabling customers to achieve their health and wealth ambition. Through this partnership, customers of Prudential can enjoy exclusive offer on bivalent vaccination service provided by EC Healthcare via online reservation platform, amongst many other healthcare services.

EC Healthcare has been developing a one-stop, multi-disciplinary, enclosed healthcare service platform and positioning strategic collaboration with insurance giants as a crucial part of the Group's core strategy. Benefiting from the long-stand leading brand and the comprehensive healthcare services provided under the unique one-stop healthcare ecosystem, the Group formed a strategic partnership with Prudential based on mutual trust, further enriching the Group's vertically integrated healthcare ecosystem. With the shared "Client-centric" belief, the Group will partner with Prudential to make premium preventive and precision medicine affordable, attainable, and sustainable to customers.

Mr. Leslie Lu, Executive Director and Co-CEO of EC Healthcare said, "We are glad to partner with Prudential, the Hong Kong leading insurance product provider, to provide premium and diversified healthcare services. Hong Kong's private healthcare market has huge potential. We believe that the strategic partnership will boost higher customer public traffic with strong synergy in the healthcare sector, enhance the organic growth of the Group's medical and healthcare business. In the future, we will forge ahead with our deep strategic cooperation with the key players in the technology, telecommunications, insurance, property and pharmaceutical industries to enrich EC Healthcare's enclosed healthcare ecosystem."

Mr. Lawrence Lam, Chief Executive Officer of Prudential Hong Kong Limited, said, "As Prudential, we understand every customer is unique with diverse needs to realize their life goals and dreams. By joining hands with industry leaders such as EC Healthcare and by making health and financial security available at moments that matter most to our customers, we empower customers to succeed in their wellbeing and protection journey and to get the most out of life."

About EC Healthcare
EC Healthcare is Hong Kong's largest non-hospital medical service provider*, leveraging its core businesses of preventive and precision medicine, and committed to developing medical artificial intelligence by integrating its multi-disciplinary medical services. The move, which is supported by the Group's high-end branding and quality customer services, is aimed at offering customers safe and effective healthcare and medical services with professionalism. The Group is a constituent stock of the Hang Seng Composite Index and the MSCI Hong Kong Small Cap Index.

The Group principally engages in the provision of one-stop medical and health care services in Greater China. The Group provides a full range of services and products under its well-known brands, including those of its one-stop aesthetic medical solutions provider DR REBORN which has ranked first in Hong Kong by sales for years, a professional hair care center HAIR FOREST, primary care clinics jointly established with health management centre re:HEALTH, a vaccine centre Hong Kong Professional Vaccine HKPV, General outpatient clinic Tencent Doctorwork, the largest one-stop pain management centre in Hong Kong New York Medical Group, the comprehensive dental centres Bayley & Jackson Dental Surgeons, EC DENTAL CARE and Health and Care Dental Clinic, an advanced diagnostic and imaging centre HKAI, an oncology treatment centre reVIVE, a day procedure centre HKMED, a specialty clinic PREMIER MEDICAL CENTRE, SPECIALISTS CENTRAL and NEW MEDICAL CENTER, a paediatric centre PRIME CARE, a gynaecology specialist ZENITH MEDICAL CENTER AND PRENATAL DIAGNOSIS CENTRE, PathLab Medical Laboratories, Ophthalmology Center VIVID EYE and EC Veterinary Hospital and Imaging Center.

*According to independent research conducted by Frost and Sullivan in terms of revenue in 2020 and 2021


Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Blockchain Life will host the 10th Global Blockchain and Crypto Forum in Dubai

DUBAI, Feb 13, 2023 – (ACN Newswire) – The 10th Global Forum on blockchain, cryptocurrencies and mining — Blockchain Life 2023 takes place on February 27-28 in Dubai.



The event is attended by key industry players, government representatives, heads of international companies and funds, investors, promising startups teams and beginners. It's noteworthy that the Forum is a meeting point for a premium crypto audience including world Crypto Whales.

What to expect?

– Whales of the crypto industry at one place
– Top speakers with world-changing insights and analytics
– Global expo of the latest Web 3.0 technologies
– Breakthrough smart networking app
– The legendary AfterParty on the luxury yacht trip

Top speakers:

– Yat Siu – Co-Founder and Executive Chairman of Animoca Brands, Founder and CEO of Outblaze
– Sergei Khitrov – Founder of Listing.Help and Jets.Capital
– Ben Zhou – Co-founder and CEO of Bybit
– Dr. Marwan Alzarouni – CEO of Dubai Blockchain Center
– Carl Runefelt – Crypto Entrepreneur, Founder Of CryptoJobs.com
– Chris MMCrypto – Cryptocurrency Expert, Co-Founder of MMCrypto
– Gabriel Abed – Ambassador of Barbados to the UAE
– Dr. Mohamed Al Hemairy – Director of Technology Transfer Office at University of Sharjah, Blockchain & Crypto Advisor
– Manan Shah – Founder and CEO of Avalance Global Solutions and CyBirb
– Gracy Chen – Managing Director of Bitget

Where and when?

February 27 – 28, Dubai, Atlantis the Palm.

Buy a ticket now: https://blockchain-life.com/asia/en/#tickets-row

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com

Korindo Transfers Urban Forest Management to Bogor Regency Government

Bogor, Indonesia, Feb 11, 2023 – (ACN Newswire) – After three years of planting and maintenance under Korindo Foundation's care, Pakansari Stadium's urban forest (or Pakansari City Forest) was finally handed over to the Bogor Regency Government at the beginning of February 2023.


Rows of Eucalyptus deglupta trees green the areas of Pakansari City Forest in Cibinong, Bogor Regency (West Java, Indonesia) [Image: Korindo]

Chairman of Korindo Foundation Robert Seung and Bogor acting regent Iwan Setiawan signed the handover plaque. [Image: Korindo]


Korindo Foundation Chairman Robert Seung performed the handing-over ceremony with Bogor's acting regent Iwan Setiawan, the handover fulfilling the region's dream of owning a lush urban forest. Pakansari City Forest is, in fact, the first wooded area to be established in Bogor Regency.

"Through the Green Collaboration program, Korindo Group and Foundation are committed to supporting government efforts that keep our country's natural environment and our beloved Earth sustainable," said Robert Seung in his opening speech.

This green space was actually a part of the regency government's masterplan, but for several reasons, its construction was put on hold. The project only saw the light in November 2019, when Korindo Foundation agreed to help out with the development.

And that's how the commitment to revitalize the land outside Pakansari Stadium began. Starting with 1,294 Eucalyptus deglupta saplings, the Foundation kept planting until a total of 1,800 trees were reached, adorning a two-hectare area that's sectioned into six planting zones.

For the next step, tree and land maintenance, local residents were given a chance to participate. Together with the Foundation, they conducted regular plant care that involved cutting weeds, cleaning up fallen branches, and pulling tangled weeds.

"After three years, I think we can all see how these seeds we planted have very much thrived and grown so large, making this place greener and much more pleasant to the eye. And from this forest, we can enjoy cleaner and fresher air," said Robert Seung.

About Korindo
Korindo Group (Korindo) was established in 1969, and consists of companies engaged in the field of natural resources, industrial paper manufacturing, heavy industry, logistics, finance, and property. As one of the major corporate groups in Indonesia, Korindo has contributed significantly to the nation's development in various ways. Visit https://www.korindonews.com, and watch the video www.korindo.co.id/group-profile/.

Through Korindo Foundation, we have a responsibility for building sustainable communities in various fields through our Corporate Social Contribution (CSC) programs. Our CSC activities focus on strategic, systematic and sustainable programs through 5 main program pillars, namely Education, Health, Economics, Environment, and Infrastructure. Learn more at https://korindofoundation.com.

Copyright 2023 ACN Newswire. All rights reserved. http://www.acnnewswire.com